These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 10530822

  • 1. Protection with metabotropic glutamate 1 receptor antagonists in models of ischemic neuronal death: time-course and mechanisms.
    Pellegrini-Giampietro DE, Peruginelli F, Meli E, Cozzi A, Albani-Torregrossa S, Pellicciari R, Moroni F.
    Neuropharmacology; 1999 Oct; 38(10):1607-19. PubMed ID: 10530822
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Metabotropic glutamate 1 (mGlu1) receptor antagonists enhance GABAergic neurotransmission: a mechanism for the attenuation of post-ischemic injury and epileptiform activity?
    Cozzi A, Meli E, Carlà V, Pellicciari R, Moroni F, Pellegrini-Giampietro DE.
    Neuropharmacology; 2002 Aug; 43(2):119-30. PubMed ID: 12213266
    [Abstract] [Full Text] [Related]

  • 5. Biochemical and electrophysiological studies on (S)-(+)-2-(3'-carboxybicyclo(1.1.1)pentyl)-glycine (CBPG), a novel mGlu5 receptor agonist endowed with mGlu1 receptor antagonist activity.
    Mannaioni G, Attucci S, Missanelli A, Pellicciari R, Corradetti R, Moroni F.
    Neuropharmacology; 1999 Jul; 38(7):917-26. PubMed ID: 10428410
    [Abstract] [Full Text] [Related]

  • 6. Neuroprotective activity of the potent and selective mGlu1a metabotropic glutamate receptor antagonist, (+)-2-methyl-4 carboxyphenylglycine (LY367385): comparison with LY357366, a broader spectrum antagonist with equal affinity for mGlu1a and mGlu5 receptors.
    Bruno V, Battaglia G, Kingston A, O'Neill MJ, Catania MV, Di Grezia R, Nicoletti F.
    Neuropharmacology; 1999 Feb; 38(2):199-207. PubMed ID: 10218860
    [Abstract] [Full Text] [Related]

  • 7. mGluR modulation of post-traumatic neuronal death: role of NMDA receptors.
    Mukhin AG, Ivanova SA, Faden AI.
    Neuroreport; 1997 Jul 28; 8(11):2561-6. PubMed ID: 9261827
    [Abstract] [Full Text] [Related]

  • 8. Neuroprotective effects of the AMPA antagonist PNQX in oxygen-glucose deprivation in mouse hippocampal slice cultures and global cerebral ischemia in gerbils.
    Montero M, Nielsen M, Rønn LC, Møller A, Noraberg J, Zimmer J.
    Brain Res; 2007 Oct 26; 1177():124-35. PubMed ID: 17894933
    [Abstract] [Full Text] [Related]

  • 9. Selective blockade of the mGluR1 receptor reduces traumatic neuronal injury in vitro and improvesoOutcome after brain trauma.
    Faden AI, O'Leary DM, Fan L, Bao W, Mullins PG, Movsesyan VA.
    Exp Neurol; 2001 Feb 26; 167(2):435-44. PubMed ID: 11161632
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Presynaptic mGlu1 type receptors potentiate transmitter output in the rat cortex.
    Moroni F, Cozzi A, Lombardi G, Sourtcheva S, Leonardi P, Carfì M, Pellicciari R.
    Eur J Pharmacol; 1998 Apr 24; 347(2-3):189-95. PubMed ID: 9653880
    [Abstract] [Full Text] [Related]

  • 12. Neuroprotective actions of novel and potent ligands of group I and group II metabotropic glutamate receptors.
    Kingston AE, O'Neill MJ, Bond A, Bruno V, Battaglia G, Nicoletti F, Harris JR, Clark BP, Monn JA, Lodge D, Schoepp DD.
    Ann N Y Acad Sci; 1999 Apr 24; 890():438-49. PubMed ID: 10668448
    [Abstract] [Full Text] [Related]

  • 13. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors.
    Lea PM, Movsesyan VA, Faden AI.
    Br J Pharmacol; 2005 Jun 24; 145(4):527-34. PubMed ID: 15821750
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The mGlu receptor ligand (S)-4C3HPG protects neurons after global ischaemia in gerbils.
    Henrich-Noack P, Hatton CD, Reymann KG.
    Neuroreport; 1998 Apr 20; 9(6):985-8. PubMed ID: 9601654
    [Abstract] [Full Text] [Related]

  • 18. The Neuroprotective Effects of mGlu1 Receptor Antagonists Are Mediated by an Enhancement of GABAergic Synaptic Transmission via a Presynaptic CB1 Receptor Mechanism.
    Landucci E, Berlinguer-Palmini R, Baccini G, Boscia F, Gerace E, Mannaioni G, Pellegrini-Giampietro DE.
    Cells; 2022 Sep 27; 11(19):. PubMed ID: 36230976
    [Abstract] [Full Text] [Related]

  • 19. Protection from neuronal damage induced by combined oxygen and glucose deprivation in organotypic hippocampal cultures by glutamate receptor antagonists.
    Strasser U, Fischer G.
    Brain Res; 1995 Jul 31; 687(1-2):167-74. PubMed ID: 7583301
    [Abstract] [Full Text] [Related]

  • 20. Selective activation of group II mGluRs with LY354740 does not prevent neuronal excitotoxicity.
    Behrens MM, Strasser U, Heidinger V, Lobner D, Yu SP, McDonald JW, Won M, Choi DW.
    Neuropharmacology; 1999 Oct 31; 38(10):1621-30. PubMed ID: 10530823
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.